TG Therapeutics, Inc. revenue breakdown overview

TG Therapeutics, Inc. revenue for the last year amounted to 233.66 M USD, the most of which — 233.66 M USD — came from its highest performing source at the moment, Novel Treatments for B-cell Diseases, the year earlier bringing 2.79 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought TG Therapeutics, Inc. 233.66 M USD, and the year before that — 2.79 M USD.